نتایج جستجو برای: (MHC) Class II

تعداد نتایج: 943960  

Journal: :iranian journal of immunology 0
soheyla alyasin clinical immunology and allergy, allergy research center farhad abolnezhadian department of pediatrics, division of immunology and allergy, namazi hospital, shiraz university of medical sciences, shiraz maryam khoshkhui department of clinical immunology and allergy, mashhad university of medical science , mashhad, iran

major histocompatibility complex (mhc) class ii deficiency is a primary immunodeficiency disease characterized by abnormality of mhc class ii molecules surface expression on peripheral blood lymphocytes and monocytes. clinical manifestations include extreme susceptibility to viral, bacterial, and fungal infections but the immunodeficiency is not as severe as scid (severe combined immunodeficien...

Farhad Abolnezhadian, Maryam Khoshkhui Soheyla Alyasin

Major histocompatibility complex (MHC) class II deficiency is a primary immunodeficiency disease characterized by abnormality of MHC class II molecules surface expression on peripheral blood lymphocytes and monocytes. Clinical manifestations include extreme susceptibility to viral, bacterial, and fungal infections but the immunodeficiency is not as severe as SCID (severe combined immunodeficien...

Journal: :Cell 2004

Bovine viral diarrhea virus (BVDV) is an economically important pathogen of the livestock industry worldwide. BVDV is classified into cytopathic (cp) and noncytopathic (ncp), depending on its effects on cultured cells. BVDV is known to alter the host’s immune response. Of this, major histocompatibility complex (MHC) class II molecules play a central role in the development and function of the i...

Journal: :The Journal of Immunology 2012

C Desvignes D Kaiserlian

Oral tolerance is a physiological immune mechanism, which controls the outcome of deleterious hypersensitivity reactions to environmental antigens absorbed through the gastrointestinal tract, and maintains homeostasis. Using a mouse model of oral tolerance of delayed type hypersensitivity to contact allergens, i.e. haptens, we have examined the mechanisms involved in the induction of oral toler...

2010
Adrien Kissenpfennig Bernard Malissen Angelika Stoecklinger Tekalign D. Eticha Mehrnaz Mesdaghi Josef Thalhamer Peter Hammerl

Journal: :Anticancer research 2005
Elizabeth Le Hongquan Zhang George Blanck

BACKGROUND Cell-surface major histocompatibility (MHC) class II molecules contribute to a molecular, intercellular complex that stimulates T-cells. MHC class II molecules also activate signaling pathways leading to apoptosis. Lack of CIITA, a co-activator of the MHC class II gene promoter, is responsible for lack of MHC class II on most of the MHC class II-negative melanoma cell lines. MATERI...

Journal: :jundishapur journal of microbiology 0
jale moradi department of microbiology, school of medicine, tehran university of medical sciences, tehran, ir iran mina tabrizi department of medical genetics, school of medicine, tehran university of medical sciences, tehran, ir iran maryam izad department of immunology, school of medicine, tehran university of medical sciences, tehran, ir iran nader mosavari department of tuberculosis, razi vaccine and serum research institute, karaj, ir iran mohammad mehdi feizabadi department of microbiology, school of medicine, tehran university of medical sciences, tehran, ir iran; thoracic research center, imam khomeini hospital, tehran university of medical sciences, tehran, ir iran; department of microbiology, school of medicine, tehran university of medical sciences, tehran, ir iran. tel/fax: +98-2188955810

conclusions the results revealed that the novel multi-epitope dna construct could be an effective candidate in tuberculosis vaccine development, and it is qualified to investigate its potential to induce cd4 and cd8 t- cell immune response in the experimental animal model. results mhc class i-and class ii-predicted epitopes showed a high potential to binding to human hlas alleles, with global b...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید